Cytokinetics Heart Failure Drug Needs Another Phase III Study, US FDA Panel Says

 
• By Sarah Karlin-Smith
  
heart
Advisory panel says Cryokinetics needs to do more study for a narrower indication • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers